Avantor Revenue 2018-2024 | AVTR
- Avantor revenue for the quarter ending September 30, 2024 was $1.714B, a 0.34% decline year-over-year.
- Avantor revenue for the twelve months ending September 30, 2024 was $6.820B, a 3.12% decline year-over-year.
- Avantor annual revenue for 2023 was $6.967B, a 7.26% decline from 2022.
- Avantor annual revenue for 2022 was $7.512B, a 1.71% increase from 2021.
- Avantor annual revenue for 2021 was $7.386B, a 15.52% increase from 2020.
Avantor Annual Revenue (Millions of US $) |
|
---|---|
2023 | $6,967 |
2022 | $7,512 |
2021 | $7,386 |
2020 | $6,394 |
2019 | $6,040 |
2018 | $5,864 |
2017 | $1,247 |
Avantor Quarterly Revenue (Millions of US $) |
|
---|---|
2024-09-30 | $1,714 |
2024-06-30 | $1,703 |
2024-03-31 | $1,680 |
2023-12-31 | $1,723 |
2023-09-30 | $1,720 |
2023-06-30 | $1,744 |
2023-03-31 | $1,780 |
2022-12-31 | $1,795 |
2022-09-30 | $1,857 |
2022-06-30 | $1,911 |
2022-03-31 | $1,950 |
2021-12-31 | $1,908 |
2021-09-30 | $1,834 |
2021-06-30 | $1,859 |
2021-03-31 | $1,786 |
2020-12-31 | $1,791 |
2020-09-30 | $1,605 |
2020-06-30 | $1,479 |
2020-03-31 | $1,519 |
2019-12-31 | $1,524 |
2019-09-30 | $1,504 |
2019-06-30 | $1,532 |
2019-03-31 | $1,480 |
2018-12-31 | |
2018-09-30 | $1,494 |
2018-06-30 | $1,478 |
2017-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $14.307B | $6.967B |
Avantor Inc. is a provider of critical products and services primarily to biopharma, healthcare, education & government, advanced technologies & applied materials industries. Avantor Inc. is based in Radnor, United States. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $84.995B | 10.55 |
Cencora (COR) | United States | $43.734B | 16.44 |
DiDi Global (DIDIY) | China | $22.941B | 0.00 |
Natera (NTRA) | United States | $20.871B | 0.00 |
ICON (ICLR) | Ireland | $16.879B | 15.03 |
Viatris (VTRS) | United States | $14.478B | 4.46 |
Revvity (RVTY) | United States | $13.453B | 23.37 |
BioMerieux (BMXMF) | France | $12.659B | 0.00 |
CochLear (CHEOY) | Australia | $11.807B | 0.00 |
Solventum (SOLV) | United States | $11.540B | 0.00 |
Medpace Holdings (MEDP) | United States | $10.417B | 29.35 |
Doximity (DOCS) | United States | $10.302B | 60.64 |
Charles River Laboratories (CRL) | United States | $9.314B | 18.00 |
HealthEquity (HQY) | United States | $8.212B | 41.20 |
Sonic Healthcare (SKHHY) | Australia | $8.208B | 0.00 |
Bausch + Lomb (BLCO) | Canada | $6.322B | 29.43 |
Amplifon S.p.A (AMFPF) | Italy | $5.864B | 29.89 |
Sotera Health (SHC) | United States | $3.759B | 20.11 |
Organon (OGN) | United States | $3.719B | 3.75 |
BrightSpring Health Services (BTSG) | United States | $2.967B | 63.11 |
Surgery Partners (SGRY) | United States | $2.493B | 28.42 |
Concentras Parent (CON) | United States | $2.491B | 0.00 |
Ardent Health Partners (ARDT) | United States | $2.291B | 0.00 |
GeneDx Holdings (WGS) | United States | $2.069B | 0.00 |
Premier (PINC) | United States | $2.067B | 10.76 |
PACS (PACS) | United States | $1.992B | 0.00 |
Alignment Healthcare (ALHC) | United States | $1.969B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $1.730B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.711B | 44.90 |
Teladoc Health (TDOC) | United States | $1.544B | 0.00 |
Pediatrix Medical (MD) | United States | $1.224B | 11.98 |
Progyny (PGNY) | United States | $1.208B | 24.47 |
Embecta (EMBC) | United States | $1.161B | 8.12 |
CareDx (CDNA) | United States | $1.102B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.090B | 0.00 | |
AMN Healthcare Services Inc (AMN) | United States | $0.874B | 5.91 |
QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
Agilon Health (AGL) | United States | $0.775B | 0.00 |
SBC Medicals (SBC) | United States | $0.649B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.492B | 0.00 |
InnovAge Holding (INNV) | United States | $0.478B | 0.00 |
DocGo (DCGO) | United States | $0.444B | 16.73 |
Sonida Senior Living (SNDA) | United States | $0.441B | 0.00 |
Enhabit (EHAB) | United States | $0.387B | 33.48 |
Sera Prognostics (SERA) | United States | $0.275B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.268B | 0.00 |
LifeMD (LFMD) | United States | $0.212B | 0.00 |
Biodesix (BDSX) | United States | $0.198B | 0.00 |
Beauty Health (SKIN) | United States | $0.176B | 0.00 |
Nutex Health (NUTX) | United States | $0.160B | 0.00 |
ModivCare (MODV) | United States | $0.156B | 8.44 |
MultiPlan (MPLN) | United States | $0.108B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.099B | 0.00 |
So-Young (SY) | China | $0.093B | 15.69 |
IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
OncoCyte (OCX) | United States | $0.037B | 0.00 |
NeueHealth (NEUE) | United States | $0.033B | 0.87 |
Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.023B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
Oncology Institute (TOI) | United States | $0.016B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
XWELL (XWEL) | United States | $0.008B | 0.00 |
KindlyMD (KDLY) | United States | $0.007B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
Cano Health (CANOQ) | United States | $0.001B | 0.00 |
Aclarion (ACON) | United States | $0.001B | 0.00 |